StockData
Biodesix Inc logo

Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.88−0.12 (-1.33%)

Close on Nov 17, 2026Market cap $93.69MP/E –Yield –

Biodesix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Biodesix's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.83M. For fiscal 2025 it was -$23.27M. The highest annual figure on record is -$21.37M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.27M–
FY2024Dec 31, 2024-$48.65M–
FY2023Dec 31, 2023-$22.87M–
FY2022Dec 31, 2022-$44.97M–
FY2021Dec 31, 2021-$28.22M–
FY2020Dec 31, 2020-$21.37M–
FY2019Dec 31, 2019-$21.73M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.56M–
Q1 FY2026Mar 31, 2026-$10.17M–
Q4 FY2025Dec 31, 2025$778.00K–
Q3 FY2025Sep 30, 2025-$8.88M–
Q2 FY2025Jun 30, 2025-$6.57M–
Q1 FY2025Mar 31, 2025-$8.60M–
Q4 FY2024Dec 31, 2024-$4.10M–
Q3 FY2024Sep 30, 2024-$10.67M–
Q2 FY2024Jun 30, 2024-$18.57M-2082.0%
Q1 FY2024Mar 31, 2024-$15.31M–
Q4 FY2023Dec 31, 2023-$12.28M–
Q3 FY2023Sep 30, 2023-$3.84M–
Q2 FY2023Jun 30, 2023$937.00K–
Q1 FY2023Mar 31, 2023-$7.69M–
Q4 FY2022Dec 31, 2022-$11.95M–
Q3 FY2022Sep 30, 2022-$10.33M–
Q2 FY2022Jun 30, 2022-$9.59M-980.2%
Q1 FY2022Mar 31, 2022-$13.10M–
Q4 FY2021Dec 31, 2021-$10.20M–
Q3 FY2021Sep 30, 2021-$7.79M–
Q2 FY2021Jun 30, 2021$1.09M–
Q1 FY2021Mar 31, 2021-$11.33M–
Q4 FY2020Dec 31, 2020-$8.76M–
Q3 FY2020Sep 30, 2020-$3.77M–
Q2 FY2020Jun 30, 2020-$4.30M–
Q1 FY2020Mar 31, 2020-$4.54M–
Q4 FY2019Dec 31, 2019-$5.73M–

More Biodesix figures

See a number that looks wrong?